DC Risk Assessment Tutorial

This tutorial gives a quick walk-through the process of documenting a risk assessment, highlighting the main features of the DC Risk Assessment application. The assessment presented in the tutorial is based on the published case study by Doe et al1.

Start an assessment In the list of your assessments click on the button 'Start a new assessment' on the top of the page.
My Assessment
Title and problem outline Provide the title of our assessment and a problem outline by clicking directly on the text.
Start an iteration Each assessment can include one or more iterations. To start a new one click on the 'Add a new iteration' button. Click on the title to specify the iteration title. The list of compounds for each iteration is copied from the previous iteration (if one exists). You can modify the list and enter the data by clicking on the 'Edit compounds' button.
Enter the data After clicking on the 'Edit compounds' button you will be taken to a new page where you can enter the data for the iteration. On this page you can add or remove compounds by clicking on the links as shown in the figure below. For each compound you can enter the compound name, that will be displayed on the graph, and the exposure and toxicity estimates for this iteration. You can search for the data in the available data sources shown in different tabs. When your entry is complete click the 'Back to assessment' button to return to the assessment page.
Write your conclusions The data entered in the previous step will be displayed on the risk matrix. You can write your conclusions for the iteration below the matrix. Conclusion for the whole assessment can be documented below the last iteration. You can edit the conclusions by clicking directly on the text.
Document the conclusions
  • (1)
    Doe JE, Lander DR, Doerrer NG, Heard N, Hines RN, Lowit AB, Pastoor T, Phillips RD, Sargent D, Sherman JH, Tanir JY, Embry MR. (2016). Use of the RISK21 roadmap and matrix: human health risk assessment of the use of a pyrethroid in bed netting. Critical Reviews in Toxicology, 46: 54-73.

“RISK21® is a registered U.S. trademark (U.S. Reg. No. 5,216,446) of the ILSI Health and Environmental Sciences Institute (HESI®). Douglas Connect and the OpenTox Association are not affiliated with, or endorsed or sponsored by HESI® or the RISK21® project.”